Reunión Clínica Octubre 2022
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled In Range trialBattelino T, Danne T, Edelman S, Choudhary P, Renard E et alDiabetes, obesity and metabolismhttps://doi.org/10.1111/dom.14898
Standards of Care in Diabetes-2023Diabetes Care December 2022, Vol.46, S1-S284https://doi.org/10.2337/dc23-Sint